We conducted a randomized and unblinded 2 2 sequential-factorial trial , composed of an induction arm ( part 1 ) comparing single-dose ( SD ) versus divided-dose rabbit antithymocyte globulin ( rATG ) , and a maintenance arm ( part 2 ) comparing tacrolimus minimization versus withdrawal .